PART 2 (LINK TO PART 1)   ReCAP is a series of interviews with the members of the RBDCOV Community Advisory Panel that will explore the world of community engagement in EU projects and the importance of including people living with immunocompromising conditions in clinical trials.   Let’s dive into the second part of the … Continue reading RECAP with the RBDCOV Community Advisory Panel | Vaccines 101: How do they make it into the European market? (part 2)